Inflammatory cortical demyelination in early multiple sclerosis

Claudia F Lucchinetti, Bogdan F G Popescu, Reem F. Bunyan, Natalia M. Moll, Shanu F. Roemer, Hans Lassmann, Wolfgang Brück, Joseph E Parisi, Bernd W. Scheithauer, Caterina Giannini, Stephen D. Weigand, Jayawant Mandrekar, Richard M. Ransohoff

Research output: Contribution to journalArticle

565 Citations (Scopus)

Abstract

BACKGROUND: Cortical disease has emerged as a critical aspect of the pathogenesis of multiple sclerosis, being associated with disease progression and cognitive impairment. Most studies of cortical lesions have focused on autopsy findings in patients with longstanding, chronic, progressive multiple sclerosis, and the noninflammatory nature of these lesions has been emphasized. Magnetic resonance imaging studies indicate that cortical damage occurs early in the disease. METHODS: We evaluated the prevalence and character of demyelinating cortical lesions in patients with multiple sclerosis. Cortical tissues were obtained in passing during biopsy sampling of white-matter lesions. In most cases, biopsy was done with the use of stereotactic procedures to diagnose suspected tumors. Patients with sufficient cortex (138 of 563 patients screened) were evaluated for cortical demyelination. Using immunohistochemistry, we characterized cortical lesions with respect to demyelinating activity, inflammatory infiltrates, the presence of meningeal inflammation, and a topographic association between cortical demyelination and meningeal inflammation. Diagnoses were ascertained in a subgroup of 77 patients (56%) at the last follow-up visit (at a median of 3.5 years). RESULTS: Cortical demyelination was present in 53 patients (38%) (104 lesions and 222 tissue blocks) and was absent in 85 patients (121 tissue blocks). Twenty-five patients with cortical demyelination had definite multiple sclerosis (81% of 31 patients who underwent long-term follow-up), as did 33 patients without cortical demyelination (72% of 46 patients who underwent long-term follow-up). In representative tissues, 58 of 71 lesions (82%) showed CD3+ T-cell infiltrates, and 32 of 78 lesions (41%) showed macrophage-associated demyelination. Meningeal inflammation was topographically associated with cortical demyelination in patients who had sufficient meningeal tissue for study. CONCLUSIONS: In this cohort of patients with early-stage multiple sclerosis, cortical demyelinating lesions were frequent, inflammatory, and strongly associated with meningeal inflammation. (Funded by the National Multiple Sclerosis Society and the National Institutes of Health.)

Original languageEnglish (US)
Pages (from-to)2188-2197
Number of pages10
JournalNew England Journal of Medicine
Volume365
Issue number23
StatePublished - Dec 8 2011

Fingerprint

Demyelinating Diseases
Multiple Sclerosis
Inflammation
Chronic Progressive Multiple Sclerosis
Biopsy
National Institutes of Health (U.S.)
Disease Progression
Autopsy
Immunohistochemistry
Macrophages
Magnetic Resonance Imaging

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lucchinetti, C. F., Popescu, B. F. G., Bunyan, R. F., Moll, N. M., Roemer, S. F., Lassmann, H., ... Ransohoff, R. M. (2011). Inflammatory cortical demyelination in early multiple sclerosis. New England Journal of Medicine, 365(23), 2188-2197.

Inflammatory cortical demyelination in early multiple sclerosis. / Lucchinetti, Claudia F; Popescu, Bogdan F G; Bunyan, Reem F.; Moll, Natalia M.; Roemer, Shanu F.; Lassmann, Hans; Brück, Wolfgang; Parisi, Joseph E; Scheithauer, Bernd W.; Giannini, Caterina; Weigand, Stephen D.; Mandrekar, Jayawant; Ransohoff, Richard M.

In: New England Journal of Medicine, Vol. 365, No. 23, 08.12.2011, p. 2188-2197.

Research output: Contribution to journalArticle

Lucchinetti, CF, Popescu, BFG, Bunyan, RF, Moll, NM, Roemer, SF, Lassmann, H, Brück, W, Parisi, JE, Scheithauer, BW, Giannini, C, Weigand, SD, Mandrekar, J & Ransohoff, RM 2011, 'Inflammatory cortical demyelination in early multiple sclerosis', New England Journal of Medicine, vol. 365, no. 23, pp. 2188-2197.
Lucchinetti CF, Popescu BFG, Bunyan RF, Moll NM, Roemer SF, Lassmann H et al. Inflammatory cortical demyelination in early multiple sclerosis. New England Journal of Medicine. 2011 Dec 8;365(23):2188-2197.
Lucchinetti, Claudia F ; Popescu, Bogdan F G ; Bunyan, Reem F. ; Moll, Natalia M. ; Roemer, Shanu F. ; Lassmann, Hans ; Brück, Wolfgang ; Parisi, Joseph E ; Scheithauer, Bernd W. ; Giannini, Caterina ; Weigand, Stephen D. ; Mandrekar, Jayawant ; Ransohoff, Richard M. / Inflammatory cortical demyelination in early multiple sclerosis. In: New England Journal of Medicine. 2011 ; Vol. 365, No. 23. pp. 2188-2197.
@article{c98cb969eb5f481b8bd7aee227bcdb2f,
title = "Inflammatory cortical demyelination in early multiple sclerosis",
abstract = "BACKGROUND: Cortical disease has emerged as a critical aspect of the pathogenesis of multiple sclerosis, being associated with disease progression and cognitive impairment. Most studies of cortical lesions have focused on autopsy findings in patients with longstanding, chronic, progressive multiple sclerosis, and the noninflammatory nature of these lesions has been emphasized. Magnetic resonance imaging studies indicate that cortical damage occurs early in the disease. METHODS: We evaluated the prevalence and character of demyelinating cortical lesions in patients with multiple sclerosis. Cortical tissues were obtained in passing during biopsy sampling of white-matter lesions. In most cases, biopsy was done with the use of stereotactic procedures to diagnose suspected tumors. Patients with sufficient cortex (138 of 563 patients screened) were evaluated for cortical demyelination. Using immunohistochemistry, we characterized cortical lesions with respect to demyelinating activity, inflammatory infiltrates, the presence of meningeal inflammation, and a topographic association between cortical demyelination and meningeal inflammation. Diagnoses were ascertained in a subgroup of 77 patients (56{\%}) at the last follow-up visit (at a median of 3.5 years). RESULTS: Cortical demyelination was present in 53 patients (38{\%}) (104 lesions and 222 tissue blocks) and was absent in 85 patients (121 tissue blocks). Twenty-five patients with cortical demyelination had definite multiple sclerosis (81{\%} of 31 patients who underwent long-term follow-up), as did 33 patients without cortical demyelination (72{\%} of 46 patients who underwent long-term follow-up). In representative tissues, 58 of 71 lesions (82{\%}) showed CD3+ T-cell infiltrates, and 32 of 78 lesions (41{\%}) showed macrophage-associated demyelination. Meningeal inflammation was topographically associated with cortical demyelination in patients who had sufficient meningeal tissue for study. CONCLUSIONS: In this cohort of patients with early-stage multiple sclerosis, cortical demyelinating lesions were frequent, inflammatory, and strongly associated with meningeal inflammation. (Funded by the National Multiple Sclerosis Society and the National Institutes of Health.)",
author = "Lucchinetti, {Claudia F} and Popescu, {Bogdan F G} and Bunyan, {Reem F.} and Moll, {Natalia M.} and Roemer, {Shanu F.} and Hans Lassmann and Wolfgang Br{\"u}ck and Parisi, {Joseph E} and Scheithauer, {Bernd W.} and Caterina Giannini and Weigand, {Stephen D.} and Jayawant Mandrekar and Ransohoff, {Richard M.}",
year = "2011",
month = "12",
day = "8",
language = "English (US)",
volume = "365",
pages = "2188--2197",
journal = "New England Journal of Medicine",
issn = "1533-4406",
publisher = "Massachussetts Medical Society",
number = "23",

}

TY - JOUR

T1 - Inflammatory cortical demyelination in early multiple sclerosis

AU - Lucchinetti, Claudia F

AU - Popescu, Bogdan F G

AU - Bunyan, Reem F.

AU - Moll, Natalia M.

AU - Roemer, Shanu F.

AU - Lassmann, Hans

AU - Brück, Wolfgang

AU - Parisi, Joseph E

AU - Scheithauer, Bernd W.

AU - Giannini, Caterina

AU - Weigand, Stephen D.

AU - Mandrekar, Jayawant

AU - Ransohoff, Richard M.

PY - 2011/12/8

Y1 - 2011/12/8

N2 - BACKGROUND: Cortical disease has emerged as a critical aspect of the pathogenesis of multiple sclerosis, being associated with disease progression and cognitive impairment. Most studies of cortical lesions have focused on autopsy findings in patients with longstanding, chronic, progressive multiple sclerosis, and the noninflammatory nature of these lesions has been emphasized. Magnetic resonance imaging studies indicate that cortical damage occurs early in the disease. METHODS: We evaluated the prevalence and character of demyelinating cortical lesions in patients with multiple sclerosis. Cortical tissues were obtained in passing during biopsy sampling of white-matter lesions. In most cases, biopsy was done with the use of stereotactic procedures to diagnose suspected tumors. Patients with sufficient cortex (138 of 563 patients screened) were evaluated for cortical demyelination. Using immunohistochemistry, we characterized cortical lesions with respect to demyelinating activity, inflammatory infiltrates, the presence of meningeal inflammation, and a topographic association between cortical demyelination and meningeal inflammation. Diagnoses were ascertained in a subgroup of 77 patients (56%) at the last follow-up visit (at a median of 3.5 years). RESULTS: Cortical demyelination was present in 53 patients (38%) (104 lesions and 222 tissue blocks) and was absent in 85 patients (121 tissue blocks). Twenty-five patients with cortical demyelination had definite multiple sclerosis (81% of 31 patients who underwent long-term follow-up), as did 33 patients without cortical demyelination (72% of 46 patients who underwent long-term follow-up). In representative tissues, 58 of 71 lesions (82%) showed CD3+ T-cell infiltrates, and 32 of 78 lesions (41%) showed macrophage-associated demyelination. Meningeal inflammation was topographically associated with cortical demyelination in patients who had sufficient meningeal tissue for study. CONCLUSIONS: In this cohort of patients with early-stage multiple sclerosis, cortical demyelinating lesions were frequent, inflammatory, and strongly associated with meningeal inflammation. (Funded by the National Multiple Sclerosis Society and the National Institutes of Health.)

AB - BACKGROUND: Cortical disease has emerged as a critical aspect of the pathogenesis of multiple sclerosis, being associated with disease progression and cognitive impairment. Most studies of cortical lesions have focused on autopsy findings in patients with longstanding, chronic, progressive multiple sclerosis, and the noninflammatory nature of these lesions has been emphasized. Magnetic resonance imaging studies indicate that cortical damage occurs early in the disease. METHODS: We evaluated the prevalence and character of demyelinating cortical lesions in patients with multiple sclerosis. Cortical tissues were obtained in passing during biopsy sampling of white-matter lesions. In most cases, biopsy was done with the use of stereotactic procedures to diagnose suspected tumors. Patients with sufficient cortex (138 of 563 patients screened) were evaluated for cortical demyelination. Using immunohistochemistry, we characterized cortical lesions with respect to demyelinating activity, inflammatory infiltrates, the presence of meningeal inflammation, and a topographic association between cortical demyelination and meningeal inflammation. Diagnoses were ascertained in a subgroup of 77 patients (56%) at the last follow-up visit (at a median of 3.5 years). RESULTS: Cortical demyelination was present in 53 patients (38%) (104 lesions and 222 tissue blocks) and was absent in 85 patients (121 tissue blocks). Twenty-five patients with cortical demyelination had definite multiple sclerosis (81% of 31 patients who underwent long-term follow-up), as did 33 patients without cortical demyelination (72% of 46 patients who underwent long-term follow-up). In representative tissues, 58 of 71 lesions (82%) showed CD3+ T-cell infiltrates, and 32 of 78 lesions (41%) showed macrophage-associated demyelination. Meningeal inflammation was topographically associated with cortical demyelination in patients who had sufficient meningeal tissue for study. CONCLUSIONS: In this cohort of patients with early-stage multiple sclerosis, cortical demyelinating lesions were frequent, inflammatory, and strongly associated with meningeal inflammation. (Funded by the National Multiple Sclerosis Society and the National Institutes of Health.)

UR - http://www.scopus.com/inward/record.url?scp=83155173565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83155173565&partnerID=8YFLogxK

M3 - Article

C2 - 22150037

AN - SCOPUS:83155173565

VL - 365

SP - 2188

EP - 2197

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 1533-4406

IS - 23

ER -